Skip to main content
Equibles
AYTU logo

AYTU · Aytu Biopharma, Inc · Metrics

Track AYTU — free

Use AYTU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AYTU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.05 -0.07 (-3.30%) At close · Sep 10
Rebalance outlook locked
Market Cap
$22.75M
Shares
10.73M

AYTU metrics

72 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.05
Market cap
$22.75M

Price action

20 metrics
Price change (1W)
-7.0%
Price change (30D)
-11.7%
Price change (3M)
-5.4%
Price change (6M)
-18.5%
Price change (YTD)
-18.5%
Price change (1Y)
-9.0%
Trailing year
Price change (5Y)
—
52-week high
$2.90
52-week low
$1.71
Change from 52-week high
-26.9%
Change from 52-week low
+24.0%
Annualized volatility
53.1%
Annualized volatility (3M)
40.2%
Beta
0.9
RSI (14D)
37.4
Price vs SMA 50
-5.4%
Price vs SMA 200
-11.1%
Avg volume (3M)
25,392
Relative volume
0.6
Average dollar volume
$56,848

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
10.73M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 248.7%
P / book
0.6
reciprocal yield 154.4%
FCF yield
7.2%
TTM · current market cap
Buyback yield
—
P / FCF
13.8
reciprocal yield 7.2%
P / operating cash flow
13.6
reciprocal yield 7.4%
Earnings yield
-149.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.1×
reciprocal yield 952.4%
EV / revenue historical average (5Y)
0.1×
reciprocal yield 1,018.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-13

Profitability

9 metrics
Gross margin
64.8%
Operating margin
-26.8%
Trailing 12 months
Net margin
-60.2%
Gross profit (TTM)
$36.66M
Operating profit (TTM)
−$15.16M
Net income (TTM)
−$34.05M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
2.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.11

Growth

11 metrics
Revenue growth YoY
-32.7%
Year over year
Net income growth YoY
-240.7%
Revenue (TTM)
$56.60M
Trailing 12 months
EPS growth YoY
-352.4%
Shares change YoY
+28.1%
Year over year · more shares
Revenue CAGR (3Y)
-11.8%
Revenue CAGR (5Y)
+19.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-96.9%
Return on assets
-30.5%
Debt / equity
0.3
Current ratio
1.1
EBITDA (TTM)
−$10.89M
Free cash flow (TTM)
$1.64M
Quick ratio
1.0
Interest coverage
-6.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$26.71M
Total assets
$111.69M
Total debt
$11.41M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.68M
Capital expenditures (TTM)
$34,000
R&D (TTM)
$216,000
SG&A (TTM)
$51.14M
Stock compensation (TTM)
$658,000
R&D / revenue
0.4%
Stock compensation / revenue
1.2%

Ownership (13F)

3 metrics
13F filers
38
13F filer change QoQ
+1
Institutional ownership
35.7%

Short interest

3 metrics
Short interest
3.1%
Latest settlement · 12.4 days to cover
Days to cover
12.4d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1385818 CUSIP 054754858 13F (30d) 24 filings 24 filers Visit website Investor relations